Simpkins, Alexis N. http://orcid.org/0000-0001-7529-4267
Busl, Katharina M.
Amorim, Edilberto
Barnett-Tapia, Carolina
Cervenka, Mackenzie C.
Dhakar, Monica B.
Etherton, Mark R.
Fung, Celia
Griggs, Robert
Holloway, Robert G.
Kelly, Adam G.
Khan, Imad R.
Lizarraga, Karlo J.
Madagan, Hannah G.
Onweni, Chidinma L.
Mestre, Humberto
Rabinstein, Alejandro A.
Rubinos, Clio
Dionisio-Santos, Dawling A.
Youn, Teddy S.
Merck, Lisa H.
Maciel, Carolina B.
Amorim, Edilberto
Barnett-Tapia, Carolina
Brown, Jeremy
Busl, Katharina M.
Cervenka, Mackenzie
Claassen, Jan
Dhakar, Monica
Dylla, Layne
Elie, Marie-Carmelle
Etherton, Mark
Fiscella, Kevin
Foreman, Brandon
Forgacs, Peter
Griggs, Robert C.
Halterman, Marc
Harriott, Andrea
Hirsch, Lawrence J.
Hocker, Sara
Holloway, Robert
Jules, Rebecca
Kelly, Adam G.
Lackland, Daniel
Lerario, Mackenzie P.
Lizarraga, Karlo J.
Maciel, Carolina B.
Merck, Lisa H.
Mitchell, Gordon
Ngwenya, Laura B.
Nogueira, Raul G.
Pierre, Clifford
Provencio, Javier
Rabenstein, Alejandro A.
Roberts, Debra
Rubinos, Clio
Scharf, Eugene
Sheth, Kevin N.
Simpkins, Alexis N.
Thurman, Cleopatra
Ullrich, Lauren
Zammit, Christopher
,
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (NS11956-01)
Article History
Received: 14 June 2020
Accepted: 19 August 2020
First Online: 21 September 2020
Conflict of interest
: Dr. Simpkins has nothing to disclose; Dr. Busl reports personal fees from Guidepoint Global, personal fees from Techspert, other from American Academy of Neurology, outside the submitted work; Dr. Amorim has nothing to disclose; Dr. Barnett reports grants from Octapharma, grants from Grifols, personal fees from Alexion, personal fees from Takeda, personal fees from Akcea, personal fees from CSL, outside the submitted work; Dr. Cervenka reports grants and personal fees from Nutricia, grants from Vitaflo, grants from BrightFocus Foundation, personal fees from Demos, personal fees from Glut2 Deficiency Foundation, outside the submitted work; Dr. Dhakar reports personal fees from Adamas Pharmaceuticals, outside the submitted work; Dr. Etherton has nothing to disclose; Ms. Fung has nothing to disclose; Dr. Griggs reports grants from Strongbridge Biopharma, grants from Attune Medical, during the conduct of the study; grants from PTC Therapeutics (formerly Marathon Pharma), grants from Sarepta Therapeutics, grants from Foundation to Eradicate Duchenne (FED), grants from Muscular Dystrophy Association (MDA), grants from Parent Project Muscular Dystrophy (PPMD), outside the submitted work; Dr. Holloway has nothing to disclose; Dr. Kelly has nothing to disclose; Dr. Khan has nothing to disclose; Dr. Lizarraga has nothing to disclose; Ms. Madagan has nothing to disclose; Dr. Merck reports grants from NIH, grants from DoD, grants from Bill and Melinda Gates Foundation, outside the submitted work; Dr. Mestre has nothing to disclose; Dr. Rabinstein has nothing to disclose; Dr. Rubinos has nothing to disclose; Dr. Youn has nothing to disclose; Dr. Maciel has nothing to disclose.